Sorrento Therapeutics appoints two independent directors
Staff Writer |
San Diego, Ca., USA - October 3, 2017, San Diego, Ca., USA - Sorrento Therapeutics, an oncology company, appointed Dorman Followwill and David Lemus as an independent directors of the company.
Article continues below
Dorman Followwill has been Senior Partner, Transformational Health at Frost & Sullivan, a business consulting firm involved in market research and analysis, growth strategy consulting and corporate training across multiple industries, since 2016.
Prior to that time, Mr. Followwill served in various roles at Frost & Sullivan, including Partner on the Executive Committee managing the P&L of the business in Europe, Israel and Africa, and Partner overseeing the Healthcare and Life Sciences business in North America, since initially joining Frost & Sullivan to help found the Consulting practice in January 1988.
Mr. Followwill has more than 30 years of organizational leadership and management consulting experience, having worked on hundreds of consulting projects across all major regions and across multiple industry sectors, each project focused around the strategic imperative of growth.
Mr. Followwill obtained his BA from Stanford University in The Management of Organizations in 1985.
David Lemus currently serves as a non-executive board member of BioHealth Innovation, Inc., The MIT Club of Washington DC and Proteros BioScience GmbH.
Most recently, from January 2016 to May 2017, Mr. Lemus served as Interim Chief Financial Officer and Chief Operating Officer of Medigene AG, a publicly-listed German biotechnology company focused on T-Cell-Receptor based immunotherapies.
Prior to that time, at Sigma Tau Pharmaceuticals, Inc., he served in the roles of Chief Executive Officer, Chief Operating Officer, and V.P. Finance in the period from 2011 to 2015.
Before this, Mr. Lemus launched Germany's first biotech IPO, serving as Chief Financial Officer and Executive V.P. of MorphoSys AG from 1998 to 2011.
Prior to his role at MorphoSys AG, he held various positions, including Operations Manager and Controller (Pharma International Division) at Hoffman La Roche, Group Treasurer of Lindt & Spruengli AG and Treasury Consultant for Electrolux AB.
Mr. Lemus received an M.S. from the Massachusetts Institute of Technology Sloan School of Management in 1988 and a B.S. in Accounting from the University of Maryland in 1984. ■